Your browser doesn't support javascript.
loading
Controlling Risk Factors Reduces Cancer Risk in Patients with Atherosclerotic Cardiovascular Disease: A Cohort Study.
Yue, Qing; Yang, Ling; Liu, Tong; Feng, Baoyu; Li, Yun; Wang, Gang; Wei, Zhihao; Song, Zongshuang; Zhao, Haiyan; Wu, Shouling.
Afiliação
  • Yue Q; School of Public Health, North China University of Science and Technology, Tangshan, China.
  • Yang L; School of Public Health, North China University of Science and Technology, Tangshan, China.
  • Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
  • Feng B; Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences; School of Basic Medicine Peking Union Medical College, Beijing, China.
  • Li Y; School of Public Health, North China University of Science and Technology, Tangshan, China.
  • Wang G; Department of Oncology.
  • Wei Z; School of Public Health, North China University of Science and Technology, Tangshan, China.
  • Song Z; School of Public Health, North China University of Science and Technology, Tangshan, China.
  • Zhao H; Department of Cardiology, Kailuan General Hospital, Tangshan, China.
  • Wu S; Department of Cardiology, Kailuan General Hospital, Tangshan, China. Electronic address: drwusl@163.com.
Am J Med ; 137(4): 341-349.e7, 2024 04.
Article em En | MEDLINE | ID: mdl-38135014
ABSTRACT

BACKGROUND:

The association of atherosclerotic cardiovascular disease (ASCVD) with cancer occurrence is not well examined, and the impact of common risk factors on the risk of cancer in ASCVD patients is not known. This study aimed to explore the effect and possible causes of ASCVD on cancer risk through a cohort study.

METHODS:

A total of 14,665 age- and sex-matched pairs of participants were recruited from the Kailuan cohort (ASCVD vs non-ASCVD). A competing risk model was used to calculate the risk of cancer after ASCVD.

RESULTS:

A total of 1124 cancers occurred after 5.80 (3.05-9.44) years of follow-up. The ASCVD group had a reduced risk of cancer (hazard ratio 0.74; 95% confidence interval, 0.65-0.85). Also, the risk of cancer in the digestive system, respiratory system, urinary system, and reproductive system was reduced by 17%, 16%, 14%, and 52%, respectively. According to the status of systolic and diastolic blood pressure, fasting blood glucose, high-sensitivity C-reactive protein and body mass index after ASCVD, the risk of overall cancer and digestive system cancer decreased with the increase in the number of ideal indicators (P for trend < .01). With the increase of follow-up time, the risk of cancer and the 5 site-specific cancers gradually decreased.

CONCLUSIONS:

Cancer risk can be reduced by controlling for common risk factors after ASCVD event. This risk reduction is site-specific-, time-, and the number of ideal indicator-dependent.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose / Neoplasias Limite: Humans Idioma: En Revista: Am J Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose / Neoplasias Limite: Humans Idioma: En Revista: Am J Med Ano de publicação: 2024 Tipo de documento: Article